Articles by Editor

First mover advantage is not to be sniffed at. However, history is littered with first movers being usurped by latecomers. Could vaccine specialist Vaxart (VXRT) join the list of late disruptors?The small-cap biotech is far behind its mostly bigger competitors in the development of a COVID-19 vaccine. Yet, after its investigational new drug (IND) application was approved by the FDA last week, Vaxart can finally proceed with the Phase 1 trial of its candidate, which is expected to kick off by the end of the month.H.C. Wainwright analyst Vernon Bernardino believes the biotech’s offering already boasts one significant differentiator to …read more […]

PPP is a better option than the Fed’s lending facility, Powell said. …read more […]

Investors are laser focused on the impact of the elections as President Trump’s odds of winning reelection continue to align with stock prices. …read more […]

Shares of Twitter jumped on Wednesday, outperforming the broader market, following an upgrade at Pivotal Research Group. The firm also boosted its price target on the stock to $36. The bullish call comes on optimism for advertising as live sports and events return and a potential subscription business. The Final Round panel discusses. …read more […]

Tesla’s lead in electric vehicle technologies has other automakers making desperate moves to catch up. …read more […]

Legal questions now loom after electric truck entrepreneur, Trevor Milton, stepped down Monday as executive chairman and board member of his newly public company Nikola. …read more […]

GoodRx Holdings Inc. shares opened trading at $46 after its $1.14 billion IPO priced at $33 per share. The CEO Doug Hirsch joined Yahoo Finance’s On The Move to discuss the IPO. …read more […]

Another 840,000 Americans are expected to have filed for first-time unemployment benefits last week, ticking down only slightly from the prior week to reaffirm a slowdown in the U.S. economic recovery. …read more […]

Johnson & Johnson Chief Scientific Officer Paul Stoffels joins Yahoo Finance’s Zack Guzman and Anjalee Khemlani to discuss the latest on a possible coronavirus vaccine, as Johnson & Johnson begins trials of its one-shot vaccine. …read more […]

Yahoo Finance’s On the Move panel discuss Tesla’s Battery Day and the reported Tesla network outage. …read more […]

On Monday, shares of Aurora Cannabis (ACB) surged by 16% following an analyst upgrade and in anticipation of what investors hoped would be a positive earnings report to mark a turnaround from recent travails. However, the results followed what is by now a familiar story and on Tuesday, Aurora handed all the fresh gains back to the market with interest.So, what happened? Although FQ4 revenue came in at C$72.11 million and beat the estimates by C$0.62 million, it still represented a year-over-year decline of 4.5% and a 5% drop from the previous quarter. Consumer revenue dropped by 9% from F3Q …read more […]

Wednesday Wealth Recap

When investors wonder whether to buy a stock, insider buying is one of the best clues they can hope for. Alexander Green explains how to interpret this signal correctly.
It’s been a tough year. And now we may be in a market bubble. But it’s not all bad. As Nicholas Vardy notes, there’s more than one way to profit from a market downturn.
It’s spooky season. But that doesn’t mean your investing returns should be scary. Chief Trends Strategist Matthew Carr proves it with the top Halloween stocks to buy.
Will you ever get to see a blockbuster movie in theaters …read more […]

Dr. Mati Hlatshwayo Davis, Infectious Disease Physician at Washington University School of Medicine and the John Cochran VA Medical Center, joins Yahoo Finance’s Zack Guzman to break down the latest coronavirus developments as the U.S. death counts surpasses 200,000. …read more […]

Here’s really why stocks are losing a ton of steam right now. …read more […]

Dividends are a key component of stock market returns. They’re also a top source of passive income. Whether you’re new or already an experienced investor, this guide will show you a unique and useful view on dividend investing.
With the insight below, you should be able to better determine if dividend investing is right for you. And to start, let’s ask this important question…

Are Dividend Stocks Worth It?
The stock market is one of the largest wealth creators in the world. Going one step further, dividend stocks give ownership in some of the top companies. They have proven cashflows and this allows …read more […]